Prevalence, Consequences, and Implications for Clinical Trials of Unrecognized Myocardial Infarction
- 15 March 2013
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 111 (6), 914-918
- https://doi.org/10.1016/j.amjcard.2012.11.042
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Vorapaxar in the Secondary Prevention of Atherothrombotic EventsThe New England Journal of Medicine, 2012
- Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul StudyClinical Research in Cardiology, 2010
- Detecting Unrecognized Myocardial Infarction: The Importance of ImagingCurrent Cardiology Reports, 2010
- The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart DiseaseCirculation, 2009
- What Is the Significance of Unrecognized Non-Q-Wave Myocardial Infarction?PLoS Medicine, 2009
- Unrecognized Non-Q-Wave Myocardial Infarction: Prevalence and Prognostic Significance in Patients with Suspected Coronary DiseasePLoS Medicine, 2009
- Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial InfarctionCirculation, 2008
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Incidence and Prognosis of Unrecognized Myocardial InfarctionThe New England Journal of Medicine, 1984
- The electrocardiogram in epidemiologic investigations. A new classification system.Circulation, 1982